Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and specific sgRNA thereof

A colorectal cancer cell, specific technology, applied in the field of gRNA, can solve the problem that the molecular mechanism of colorectal cancer is not yet clear

Inactive Publication Date: 2018-10-12
OBIO TECH SHANGHAI CORP LTD
View PDF1 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, researchers have done a lot of research on the pathogenesis of colorectal cancer, and have discovered many pathways and mechanisms involved in the progression of colorectal cancer, such as activation of proto-oncogenes, inactivation of tumor suppressor genes (point mutations, rearrangements, deletions) and chromosomal Abnormalities, etc., but the molecular mechanisms involved in the occurrence and progression of colorectal cancer are still unclear, and further research is needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and specific sgRNA thereof
  • CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and specific sgRNA thereof
  • CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and specific sgRNA thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] 1. Using CRISPR / Cas9 technology to construct a knockout PPP1R1C plasmid

[0045] 1.1 sgRNA oligonucleotide chain synthesis

[0046] Using the CRISPR online design tool (http: / / crispr.mit.edu / ) according to the scoring system, a 20bp sgRNA was designed on the third exon of PPP1R1C, and no non-specific genes were verified by BLAST. ACCG was added to the 5' end of the coding strand template, and AAAC was added to the 3' end of the non-coding strand template to complement the cohesive ends formed after digestion with BsmBI, and a pair of CRISPR oligonucleotide chains were designed, as shown in Table 1.

[0047] Table 1 PPP1R1C targeting site and sgRNA oligonucleotide sequence list

[0048]

[0049] 1.2 Vector construction

[0050] 1.2.1 Use BsmBI to digest 2 μg of Lenti-CRISPRv2 plasmid (purchased from Addgene), 2h, 37°C:

[0051] enzyme digestion system

[0052] 2μg (2μl)

Lenti-CRISPRv2

1μl

BsmBI (NEB)

5μl

10X Cutsmart

42μl ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and a specific sgRNA sequence. The invention comprises the following steps: firstly, acquiring sgRNA of a specific targeting PPP1R1C gene functional area, wherein a base sequence of the sgRNA is shown as SEQ ID NO.1; then, constructing an sgRNA-lentiviral vector system of the PPP1RQC gene, wherein thesystem contains Cas9 protein; and finally, infecting human colorectal cancer HT-29 cells with CRISPR / Cas9 lentivirus containing the sgRNA, so that a cell line that a PPP1R1C protein expression levelis obviously reduced is obtained. The invention is simple in operating steps, good in sgRNA targeting performance and high in cutting efficiency on the PPP1R1C gene; the constructed CRISPR / Cas9 lentiviral system is high in knockout efficiency and is capable of achieving specific knockout of the PPP1R1C gene, so that the human colorectal cancer cells that the PPP1R1C gene is knocked out is obtained; therefore, a powerful tool is provided for further researching an action mechanism of the PPP1R1C in the colorectal cancer cells.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and more specifically relates to CRISPR / Cas9 targeted knockout of human intestinal cancer cell PPP1R1C gene and its specific gRNA. Background technique [0002] Protein phosphatase 1 (PP1) has serine / threonine phosphatase activity and is widely involved in cell signal transduction processes. Protein kinases and protein phosphatases can phosphorylate and dephosphorylate a variety of proteins, thereby changing the charge, solubility, and binding capacity of enzymes, receptors, and ion channels. They are widely involved in cell division, gene expression regulation, and neural information transmission. , muscle contraction and cell signal transduction and other important life processes. Impaired activity of protein phosphatases PP1 and PP2A can lead to cell dysfunction, such as tumors and abnormal neuronal differentiation. Protein phosphatase 1 regulatory inhibitor subunit 1C (protein phosphatase...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/867C12N5/10C12N15/90
Inventor 杨佳丽杨兴林潘讴东夏清梅刘梅锐
Owner OBIO TECH SHANGHAI CORP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products